Real-world data shows: hybrid support is the future of patient adherence

Sciensus has presented real-world data demonstrating the effectiveness of our hybrid patient support programme model to improve medication adherence and persistence. The findings, recently presented at ISPOR EU in Glasgow, underscore the unique value of our end-to-end commercial service offering by demonstrating that combining digital technology with expert human clinical care is an effective way to keep patients on treatment.

Our retrospective, database study of over 35,000 patients initiating home-based, self-administered therapy clearly showed the benefits of integrated care:

• Digital boost: Patients who received digital support via our Sciensus Intouch app were almost twice as likely to be adherent at 12 months compared to those on base support alone.
• Peak persistence: Higher persistence rates were achieved when digital tools were seamlessly combined with in-person or remote nurse support. This hybrid approach creates a continuous, patient-centric support system that truly drives behaviour change.

Our integrated model is built on a unique, direct connection with patients. This relationship is the foundation that allows us to deploy the right clinical and digital interventions at the right time, maximising the therapeutic benefit of complex medicines. Ultimately, sustained treatment means better real-world outcomes for patients.

Click here to read the press release